Fabian Heinemann

Fabian Heinemann

Auto-generated profile, based on publicly available information

Fabian Heinemann

Drug Discovery Sciences Boehringer Ingelheim Pharma GmbH and Co Biberach an der Riß Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2013 in eLife
Verified
Journal Article
Open access
SVSven K Vogel
Sven K Vogel
ZPZdenek Petrasek
Zdenek Petrasek
FHFabian Heinemann
Fabian Heinemann
PSPetra Schwille
Petra Schwille
Cell cortex remodeling during cell division is a result of myofilament-driven contractility of the cortical membrane-bound actin meshwork. Little is known about the interaction between individual myofilaments and membrane-bound actin filaments. Here we reconstituted a minimal actin cortex to directly visualize the action of individual myofilaments on membrane-bound actin filaments using TIRF microscopy. We show that synthetic myofilaments fragment and compact membrane-bound actin while processively moving along actin filaments. We propose a mechanism by which tension builds up between the ends of myofilaments, resulting in compressive stress exerted to single actin filaments, causing their buckling and breakage. Modeling of this mechanism revealed that sufficient force (∼20 pN) can be generated by single myofilaments to buckle and break actin filaments. This mechanism of filament fragmentation and compaction may contribute to actin turnover and cortex reorganization during cytokinesis.

1 April 2013 in Biophysical Journal
Verified
Journal Article
Closed access
PDF file
FHFabian Heinemann
Fabian Heinemann
SVSven K. Vogel
Sven K. Vogel
PSPetra Schwille
Petra Schwille

1 January 2011 in Biophysical Chemistry
Verified
Journal Article
Closed access
FHFabian Heinemann
Fabian Heinemann
MLMalte Launspach
Malte Launspach
KGKatharina Gries
Katharina Gries
MFMonika Fritz
Monika Fritz

1 October 2006 in Biophysical Journal
Verified
Journal Article
Closed access
PDF file
LTLaura Treccani
Laura Treccani
KMKarlheinz Mann
Karlheinz Mann
FHFabian Heinemann
Fabian Heinemann
MFMonika Fritz
Monika Fritz

5 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FHFabian Heinemann
Fabian Heinemann
GBGerald Birk
Gerald Birk
BSBirgit Stierstorfer
Birgit Stierstorfer
Non-alcoholic fatty liver disease (NAFLD) and the progressive form of non-alcoholic steatohepatitis (NASH) are diseases of major importance with a high unmet medical need. Efficacy studies on novel compounds to treat NAFLD/NASH using disease models are frequently evaluated using established histological feature scores on ballooning, inflammation, steatosis and fibrosis. These features are assessed by a trained pathologist using microscopy and assigned discrete scores. We demonstrate how to automate these scores with convolutional neural networks (CNNs). Whole slide images of stained liver sections are analyzed using two different scales with four CNNs, each specialized for one of four histopathological features. A continuous value is obtained to quantify the extent of each feature, which can be used directly to provide a high resolution readout. In addition, the continuous values can be mapped to obtain the established discrete pathologist-like scores. The automated deep learning-based scores show good agreement with the trainer - a human pathologist.

1 August 2007 in Biophysical Journal
Verified
Journal Article
Closed access
PDF file
KMKarlheinz Mann
Karlheinz Mann
FSFrank Siedler
Frank Siedler
LTLaura Treccani
Laura Treccani
FHFabian Heinemann
Fabian Heinemann
MFMonika Fritz
Monika Fritz